Beyond Particle Counting: Why Modern Biologics Need Particle Forensics

In biologics development, particle counts often trigger concern—but numbers alone rarely explain the real risk. What matters just as much is particle identity, origin, and behavior over time. This perspective reframes how teams should interpret particle data, moving beyond simple thresholds to informed decision-making. This whitepaper explores why traditional MFI-based particle counting can generate misleading signals that stall programs unnecessarily, and how deeper classification provides clarity. It introduces a machine-learning–driven approach to particle identification, paired with scientific interpretation grounded in formulation and process knowledge. Through a real-world case study, readers see how rapid differentiation between benign and harmful particles prevented a low-dose biologic from being wrongly flagged.

For teams navigating complex stability challenges, this is a practical look at how particle data can become a strategic asset rather than a recurring obstacle.